Publication | Closed Access
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2
30
Citations
32
References
2021
Year
Hematological MalignancyNovel TherapyNatural SciencesReceptor Tyrosine KinaseMalignant Blood DisorderEnzyme Josd1Molecular BiologyMutant Jak2MedicineCell BiologyCell SignalingSmall Molecule InhibitionSmall MoleculesJak-stat Signaling PathwayMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1